A medicinal chemistry case study: An account of an angiotensin II antagonist drug discovery programme
- 1 January 1994
- journal article
- Published by Elsevier in Tetrahedron
- Vol. 50 (46) , 13049-13080
- https://doi.org/10.1016/s0040-4020(01)89316-9
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.Hypertension, 1992
- The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonistMedicinal Research Reviews, 1992
- Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtypeJournal of Medicinal Chemistry, 1991
- 1-(Carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonistsJournal of Medicinal Chemistry, 1991
- Bromobenzofurans : a new class of potent, non-peptide antagonists of angiotensin IIBioorganic & Medicinal Chemistry Letters, 1991
- Part VI. Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensivesJournal of Medicinal Chemistry, 1990
- The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensivesJournal of Medicinal Chemistry, 1990
- Identification of angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Recent developments in the design of angiotensin‐converting enzyme inhibitorsMedicinal Research Reviews, 1985
- Angiotensin‐converting enzyme inhibitors: Medicinal chemistry and biological actionsMedicinal Research Reviews, 1982